{
    "Trade/Device Name(s)": [
        "ACE Alera Clinical Chemistry System",
        "ACE Glucose Reagent",
        "ACE Ion Selective Electrode (ISE) Module"
    ],
    "Submitter Information": "Alfa Wassermann Diagnostic Technologies, LLC",
    "510(k) Number": "K123018",
    "Predicate Device Reference 510(k) Number(s)": [
        "K930140",
        "K933862",
        "K930104",
        "K113253"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CFR",
        "JGS",
        "CEM",
        "CGZ",
        "JJE"
    ],
    "Summary Letter Date": "April 23, 2013",
    "Summary Letter Received Date": "March 5, 2013",
    "Submission Date": "February 27, 2013",
    "Regulation Number(s)": [
        "21 CFR 862.1345",
        "21 CFR 862.1665",
        "21 CFR 862.1600",
        "21 CFR 862.1170",
        "21 CFR 862.2160"
    ],
    "Regulation Name(s)": [
        "Glucose test system",
        "Electrode, ion specific, sodium, potassium, chloride",
        "Analyzer, chemistry (photometric, discrete), for clinical use"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose",
        "Sodium",
        "Potassium",
        "Chloride"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Lithium heparin plasma"
    ],
    "Specimen Container(s)": [
        "Serum tube",
        "Lithium heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "ACE Alera Clinical Chemistry System",
        "ACE Clinical Chemistry System",
        "ACE Axcel Clinical Chemistry System"
    ],
    "Method(s)/Technology(ies)": [
        "Photometric",
        "Potentiometric",
        "Hexokinase enzymatic",
        "Ion-selective electrode"
    ],
    "Methodologies": [
        "Quantitative measurement",
        "Automated discrete analysis"
    ],
    "Submission Type(s)": [
        "Analyzer",
        "Reagent",
        "Module"
    ],
    "Document Summary": "FDA 510(k) summary for ACE Alera Clinical Chemistry System, Glucose Reagent, and ISE Module for quantitative measurement of glucose and electrolytes in serum and plasma.",
    "Indications for Use Summary": "For in vitro diagnostic quantitative measurement of glucose, sodium, potassium, and chloride in serum and lithium heparin plasma for clinical use in physician office and clinical laboratories.",
    "fda_folder": "Clinical Chemistry"
}